Sponsor:
National Cancer Institute (NCI)
Code:
NCT05886036
Conditions
Nodular Lymphocyte Predominant B-Cell Lymphoma
Recurrent Nodular Lymphocyte Predominant B-Cell Lymphoma
Refractory Nodular Lymphocyte Predominant B-Cell Lymphoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Biopsy Procedure
Biospecimen Collection
Bone Marrow Biopsy
Computed Tomography
Fludeoxyglucose F-18
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-08-20. This information was provided to ClinicalTrials.gov by National Cancer Institute (NCI) on 2025-05-22.